NET PROFIT (x1000 DKK)
EMPLOYEES
Biobad Scand. AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-22
|
-3
|
-1 |
| EBITDA |
-22
|
-3
|
-1 |
| Total assets |
20
|
42
|
47 |
| Current assets |
20
|
42
|
47 |
| Current liabilities |
3
|
2
|
0 |
| Equity capital |
17
|
40
|
47 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
85.0%
|
95.2%
|
100% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-110.0%
|
-7.1%
|
-2.1% |
| Current ratio |
666.7%
|
2100% | |
| Return on equity (ROE) |
-129.4%
|
-7.5%
|
-2.1% |
| Change turnover |
0
|
0
|
-235 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.